We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Places Hydroxychloroquine Sulfate on Compounding Exception List
FDA Places Hydroxychloroquine Sulfate on Compounding Exception List
The FDA said it won’t object to outsourcing facilities using hydroxychloroquine sulfate or chloroquine phosphate for compounding during the COVID-19 pandemic.